Literature DB >> 12706302

Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis.

Elspeth J Gold1, Richard J B Francis, Arthur Zimmermann, Sally L Mellor, Mark Cranfield, Gail P Risbridger, Nigel P Groome, Antony M Wheatley, Jean S Fleming.   

Abstract

Amounts of betaA-activin, betaC-activin, activin receptor subunits ActRIIA and ActRIIB mRNA, and betaA- and betaC-activin subunit protein immunoreactivity were investigated in male Lewis rats, either untreated or after 5 or 10 weeks of CCl(4) treatment to induce cirrhosis. Apoptosis was assessed histologically and with an in situ cell death detection kit (TUNEL). Reverse transcription and polymerase chain reaction were used to evaluate mRNA levels. Activin betaA- and betaC-subunit immunoreactivity was studied by immunohistochemistry using specific monoclonal antibodies. Hepatocellular apoptosis (P<0.001), increased betaA- and betaC-activin mRNAs (three- to fourfold; P<0.01) and increased betaA- and betaC-activin tissue immunoreactivity were evident, whereas ActRIIA mRNA concentrations fell (30%; P<0.01) after 5 weeks of CCl(4) treatment. The mRNA concentrations at 10 weeks were not significantly different from controls, despite extensive hepatic nodule formation. We conclude that the increased activin subunit expression is associated with apoptosis, rather than hepatic fibrosis and nodule formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706302     DOI: 10.1016/s0303-7207(02)00417-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  15 in total

1.  Endothelial transcription factor KLF2 negatively regulates liver regeneration via induction of activin A.

Authors:  Yosif Manavski; Tobias Abel; Junhao Hu; Dina Kleinlützum; Christian J Buchholz; Christina Belz; Hellmut G Augustin; Reinier A Boon; Stefanie Dimmeler
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

2.  Effects of chronic hepatitis C genotype 1 and 4 on serum activins and follistatin in treatment naïve patients and their correlations with interleukin-6, tumour necrosis factor-α, viral load and liver damage.

Authors:  Bassem Refaat; Ahmed Mohammed Ashshi; Adel Galal El-Shemi; Adnan AlZanbagi
Journal:  Clin Exp Med       Date:  2014-06-13       Impact factor: 3.984

3.  Activins and follistatins: Emerging roles in liver physiology and cancer.

Authors:  Emanuel Kreidl; Deniz Oztürk; Thomas Metzner; Walter Berger; Michael Grusch
Journal:  World J Hepatol       Date:  2009-10-31

4.  Hepatopulmonary syndrome: the role of intra-abdominal hypertension and a novel mouse model.

Authors:  Zhaojie Zhang; Xiaolong Qi; Zhiwei Li; Lijun Xu; Fei Wang; Shenglan Wang; Yizhong Chang; Wanrong Ma; Mingxin Xu; Changqing Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

5.  Rat activin-betaE mRNA expression during development and in acute and chronic liver injury.

Authors:  Elspeth J Gold; Marcel A Monaghan; Jean S Fleming
Journal:  J Mol Genet Med       Date:  2006-04-12

Review 6.  Activins and activin antagonists in hepatocellular carcinoma.

Authors:  Alev Deli; Emanuel Kreidl; Stefan Santifaller; Barbara Trotter; Katja Seir; Walter Berger; Rolf Schulte-Hermann; Chantal Rodgarkia-Dara; Michael Grusch
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

7.  Role of activin A in carbon tetrachloride-induced acute liver injury.

Authors:  Dong-Hui Wang; Yi-Nan Wang; Jing-Yan Ge; Hai-Yan Liu; Hong-Jun Zhang; Yan Qi; Zhong-Hui Liu; Xue-Ling Cui
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

8.  Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma?

Authors:  K Frost; K Seir; A Lackner; M Grusch; B Grasl-Kraupp; R Schulte-Hermann; C Rodgarkia-Dara
Journal:  Br J Cancer       Date:  2011-03-15       Impact factor: 7.640

9.  Analysis of gene expression changes in relation to toxicity and tumorigenesis in the livers of Big Blue transgenic rats fed comfrey (Symphytum officinale).

Authors:  Nan Mei; Lei Guo; Lu Zhang; Leming Shi; Yongming Andrew Sun; Chris Fung; Carrie L Moland; Stacey L Dial; James C Fuscoe; Tao Chen
Journal:  BMC Bioinformatics       Date:  2006-09-06       Impact factor: 3.169

10.  Pegylated Interferon-α Modulates Liver Concentrations of Activin-A and Its Related Proteins in Normal Wistar Rat.

Authors:  Bassem Refaat; Adel Galal El-Shemi; Ahmed Mohamed Ashshi; Elaf Wael Mahamid; Noha Mohammed Al-Qadi
Journal:  Mediators Inflamm       Date:  2015-07-06       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.